CORCEPT THERAPEUTCS (HTD BE) stock market data APIs
€63.8834
0(0%)
as of November 14, 2025
Try our APIs with
free plan!
CORCEPT THERAPEUTCS Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for HTD.BE.
Prev. Close
63.8834
Open
63.8834
High
63.8834
Low
63.8834
52 wk Range
48-105.2
Market Cap
1 917 M
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get CORCEPT THERAPEUTCS data using free add-ons & libraries
Get CORCEPT THERAPEUTCS Fundamental Data
CORCEPT THERAPEUTCS Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-04
- EPS/Forecast: 0.14
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
CORCEPT THERAPEUTCS News
New
Branded Pharmaceuticals Stocks Q3 Recap: Benchmarking Corcept (NASDAQ:CORT)
Looking back on branded pharmaceuticals stocks’ Q3 earnings, we examine this quarter’s best and worst performers, including Corcept (NASDAQ:CORT) and its peers. Looking ahead, the branded pharmac...
Lantheus, Enovis, Evolent Health, Repligen, and Corcept Shares Are Soaring, What You Need To Know
What Happened? A number of stocks jumped in the afternoon session after the market experienced a sharp sector rotation, as investors fled growth-oriented technology stocks and piled into value-orient...
We Think You Can Look Beyond Corcept Therapeutics' (NASDAQ:CORT) Lackluster Earnings
Shareholders appeared unconcerned with Corcept Therapeutics Incorporated's (NASDAQ:CORT) lackluster earnings report last week. Our analysis suggests that while the profits are soft, the foundations of...
The 5 Most Interesting Analyst Questions From Corcept’s Q3 Earnings Call
Corcept Therapeutics’ third quarter results drew a negative market reaction as the company’s revenue missed Wall Street expectations, despite robust year-on-year growth. Management highlighted per...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
